Solicite aqui
As part of the 70th Anniversary celebration of the Andijan State Medical Institute (ASMI) in Uzbekistan, ELZA Institute CEO, Nikki Hafezi, MAS IP ETHZ, took part in a series of high-level academic and institutional events from April 28 to May 1, 2025.
A teenage boy nearly lost his sight to keratoconus from chronic eye rubbing. Discover how early diagnosis and Swiss treatment saved it.
Who is the best eye doctor in Zurich? In Switzerland? In the world? While such questions are inherently subjective, peer recognition provides a meaningful benchmark.
Medical trade journal, The Ophthalmologist seeks to answer this by publishing its biennial Power List—a global selection of the 100 most influential individuals shaping the future of ophthalmology.
No congresso do WCC 2025 em Washington, DC, o Dr. Emilio A. Torres-Netto, do ELZA Institute, apresentou uma pesquisa inovadora sobre ELZA-PACE-CXL, ELZA-sub400 CXL e Femto-CAIRS, ampliando os limites do tratamento do ceratocone.
ELZA-PACE combines epi-on cross-linking with customized PTK for keratoconus without stromal tissue removal – as reported by Ocular Surgery News
During this visit to TOS 2025, Prof. Hafezi presented ECO-CAIRS and ELZA-PACE and highlighted the Light for Sight Foundation’s work to improve care for children with Down Syndrome.
ELZA’s cornea, cataract, and refractive surgeon, Dr. Emilio Torres-Netto, MD, PhD, FWCRS, was this month appointed by the European Journal of Ophthalmology (EJO) as an Associate Editor. This honor is a reflection of Dr. Torres-Netto’s knowledge, experience, and commitment to the field of ophthalmology.
Ocular Surgery News interviewed Prof. Farhad Hafezi at ESCRS 2025 on ECO-CAIRS, a technique using ultra high-fluence corneal cross-linking (CXL) to optimize allogenic corneal ring segments before implantation, improving precision and biomechanical stability.
Prof. Farhad Hafezi, MD, PhD, FARVO, has been appointed to the Editorial Board of EuroTimes, the official publication of the European Society of Cataract and Refractive Surgeons (ESCRS). This role further solidifies his contributions to ophthalmic research, education, and innovation.
New CXL research challenges the role of oxygen in corneal cross-linking. Can oxygen-independent CXL improve keratoconus treatment? Find out how this breakthrough could change clinical practice.
Share our subscribe link:
https://www.elza-institute.com/get-the-newsletter/
Teilen Sie den Link zum Abonnieren:
https://www.elza-institute.com/de-ch/newsletter-erhalten/
